You have 9 free searches left this month | for more free features.

Angiomyolipoma

Showing 26 - 50 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
  • Heart Failure
  • Anniston, Alabama
  • +618 more
Jun 3, 2022

Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM) Trial in Worldwide (Everolimus (RAD001), Everolimus Placebo)

Completed
  • Tuberous Sclerosis Complex (TSC)
  • Lymphangioleiomyomatosis (LAM)
  • Everolimus (RAD001)
  • Everolimus Placebo
  • Birmingham, Alabama
  • +24 more
Jan 3, 2017

Migraine Trial in Japan (Galcanezumab, Placebo)

Completed
  • Migraine
  • Chiba, Japan
  • +46 more
Apr 1, 2021

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) Trial in Worldwide (Epanova®

Completed
  • Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
  • Epanova® (omega-3 carboxylic acids)
  • corn oil control
  • Birmingham, Alabama
  • +684 more
Aug 16, 2021

Ulcerative Colitis Trial in Worldwide (Apremilast, Placebo)

Completed
  • Ulcerative Colitis
  • Dothan, Alabama
  • +98 more
Apr 28, 2020

Anemia, End Stage Renal Disease (ESRD) Trial in Worldwide (Roxadustat, Epoetin alfa, Darbepoetin alfa)

Completed
  • Anemia
  • End Stage Renal Disease (ESRD)
  • Brussels, Flemish Brabant, Belgium
  • +142 more
Jan 14, 2021

Lymphangioleiomyomatosis Trial in Boston ("Sirolimus" and "Hydroxychloroquine" 200 mg, "Sirolimus" and "Hydroxychloroquine" 400

Completed
  • Lymphangioleiomyomatosis
  • "Sirolimus" and "Hydroxychloroquine" 200 mg
  • "Sirolimus" and "Hydroxychloroquine" 400 mg
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 13, 2018

Type 2 Diabetes Trial (Omarigliptin, Placebo to Omarigliptin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 8, 2018

Breast Cancer Trial in Austria (Anastrozole)

Completed
  • Breast Cancer
  • Amstetten, Austria
  • +61 more
Oct 1, 2019

Study: Renal Manifestations

Completed
  • Tuberous Sclerosis Complex
    • Cincinnati, Ohio
      Cincinnati Children's
    May 2, 2017

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    CT-P13 For Standard Of Care Treatment Of Inflammatory Bowel

    Completed
    • Inflammatory Bowel Diseases
    • +2 more
    • Leuven, Vlaams Brabant, Belgium
    • +139 more
    Jan 30, 2020

    Coronary Artery Disease Trial in Worldwide (PROMUS Coronary Stent System, PROMUS Element Coronary Stent System, Aspirin)

    Completed
    • Coronary Artery Disease
    • PROMUS Coronary Stent System
    • +3 more
    • Birmingham, Alabama
    • +132 more
    Mar 13, 2019

    Infections, Papillomavirus Trial in China (HPV GSK 580299 vaccine, Placebo control)

    Completed
    • Infections, Papillomavirus
    • HPV GSK 580299 vaccine
    • Placebo control
    • Jintan, Jiangsu, China
    • +3 more
    May 3, 2019

    Iron Deficiency Anemia, Impaired Renal Function Trial in Norristown (Ferric Carboxymaltose (FCM), Iron Sucrose (Venofer))

    Completed
    • Iron Deficiency Anemia
    • Impaired Renal Function
    • Ferric Carboxymaltose (FCM)
    • Iron Sucrose (Venofer)
    • Norristown, Pennsylvania
      Luitpold Pharmaceuticals, Inc.
    Jan 22, 2018

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Herpes Zoster Trial in Worldwide (Herpes Zoster vaccine GSK1437173A Low Dose, Herpes Zoster vaccine GSK1437173A Medium Dose,

    Completed
    • Herpes Zoster
    • Herpes Zoster vaccine GSK1437173A Low Dose
    • +4 more
    • Hradec Kralove, Czechia
    • +10 more
    Feb 22, 2019

    Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

    Completed
    • Diabetes Mellitus, Type 2
    • +2 more
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +312 more
    Nov 5, 2018

    Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)

    Completed
    • Cardiovascular Disease
    • Decatur, Georgia
    • +202 more
    Jun 12, 2018

    Adrenocortical Adenoma, Endometrial Stromal Sarcomas Trial in Worldwide (MRI, CT or ultrasound was permitted if MRI was

    Completed
    • Adrenocortical Adenoma
    • Endometrial Stromal Sarcomas
    • MRI, CT or ultrasound was permitted if MRI was contraindicated
    • +4 more
    • Tallahassee, Florida
    • +19 more
    Oct 24, 2016

    MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

    Completed
    • Major Depressive Disorder
    • Redlands, California
    • +76 more
    Mar 16, 2018

    Migraine Disorders Trial in Australia, Korea, Republic of, United States (onabotulinumtoxinA)

    Completed
    • Migraine Disorders
    • onabotulinumtoxinA
    • Scottsdale, Arizona
    • +31 more
    Nov 9, 2016

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (fluticasone furoate/vilanterol, fluticasone furoate, vilanterol)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • fluticasone furoate/vilanterol
    • +3 more
    • Andalusia, Alabama
    • +1620 more
    Aug 2, 2018

    Lymphangioleiomyomatosis, Tuberous Sclerosis Trial in Nottingham (Doxycycline, Placebo)

    Completed
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis
    • Nottingham, United Kingdom
      Nottingham University Hospitals
    Dec 1, 2015

    Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib)

    Completed
    • Chronic Myeloid Leukemia
    • Duarte, California
    • +110 more
    Jun 28, 2017